Pravastatin Solicitation

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D2-24-R-0004

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
The Defense Logistics Agency (DLA) Troop Support has issued an active solicitation, identified as SPE2D2-24-R-0004, for the procurement of Pravastatin, a pharmaceutical product. This opportunity is classified under NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further designated by Product Service Code 6505, indicating a focus on drugs and biologicals. The solicitation aims to secure a reliable supply of Pravastatin to support federal requirements, likely for military or other government healthcare needs. The scope of this procurement encompasses the manufacturing and delivery of Pravastatin in accordance with the specifications detailed in the attached solicitation document, accessible via the official SAM.gov posting. Contractors are expected to demonstrate capabilities in pharmaceutical production, quality assurance, and compliance with federal standards for drug supply. The intended outcome is to ensure the availability of high-quality Pravastatin for use by the contracting entity, supporting the health and readiness of personnel served by DLA Troop Support. Key requirements for this solicitation include adherence to all applicable regulatory standards for pharmaceutical manufacturing, as outlined in the solicitation attachment. Prospective offerors should be prepared to provide documentation of their manufacturing processes, quality control measures, and ability to meet delivery schedules. The expected deliverables are the specified quantities and formulations of Pravastatin, delivered in accordance with the terms set forth by DLA Troop Support. The contracting entity for this procurement is DLA Troop Support, a federal office responsible for supplying medical and pharmaceutical products to various government agencies. The primary point of contact for this solicitation is John Brown, who can be reached at [email protected] or by phone at 215-737-9056. A secondary contact, Catherine Gilbert, is also available at [email protected] or 215-737-4778, providing additional support for inquiries related to the solicitation. This is a formal solicitation posted on July 3, 2024, with responses due by August 4, 2024. Interested contractors should review the attached solicitation document for detailed requirements and submission instructions. The procurement is listed on SAM.gov under Opportunity ID 8c899ae5ad7d4ab29e17ec20f7ce1313, where the full notice and attachment can be accessed. No information regarding set-aside requirements or special considerations has been provided in the notice. Contractors are encouraged to consult the attached solicitation for any additional details regarding eligibility, evaluation criteria, and contract terms. This opportunity is suitable for firms with established capabilities in pharmaceutical manufacturing and a track record of compliance with federal procurement standards.